|
|
CN
Online Message×
Click switch
Integrated Solutions

Deeply integrate R & D experience, constantly climb the peak of R & D technology, and build an integrated innovation service platform for new drug R & D.

Process Department Solid Form Screening Platform
The solid screening platform of Medicilon process department strictly complies with the registration regulations and regulatory requirements of China NMPA, FDA and other regulatory authorities, studies and controls the solid morphology of drug molecules in API and preparations, and can formulate the optimal screening strategy according to the material characteristics, including but not limited to crystallization method, solvent selection and ion selection.
Salt Screening
Eutectic Screening
Polymorph Screening
Development and Verification of Qualitative, Quantitative and Limit Analysis Methods
Relevant laboratories
Return